Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katy Taylor

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Regulatory Toxicology and Pharmacology : RTP|April 29, 2014
The added value of the 90-day repeated dose oral toxicity test for industrial chemicals with a low (sub)acute toxicity profile in a high quality datasetKaty Taylor, David J Andrew, Laura Rego
ALTEX|March 11, 2014
Experiences of the REACH testing proposals system to reduce animal testingKaty Taylor, Wolfgang Stengel, Carlotta Casalegno, et al.
Alternatives to Laboratory Animals : ATLA|July 30, 2008
Estimates for worldwide laboratory animal use in 2005Katy Taylor, Nicky Gordon, Gill Langley, et al.
ALTEX|April 17, 2026
Implementation of reduction and refinement-related parameters in repeated dose toxicity studiesKaty Taylor, Laura Rego Alvarez, Emma Grange, et al.
Applied Occupational and Environmental Hygiene|May 15, 2003
Video exposure assessments demonstrate excessive laboratory formaldehyde exposuresTimothy J Ryan, G Edward Burroughs, Katy Taylor, et al.
NAM Journal|June 29, 2026
Botulinum neurotoxin: Tracking the transition from lethal dose to <i>in vitro</i> modelsJustine C Watkins, Jordi Middelkoop, Katy Taylor, et al.
Annals of Palliative Medicine|April 21, 2023
Evaluating the impact of the metastatic spinal cord compression coordinator in a regional cancer network: a prospective, non-randomized pilot studyRubyyat-A Hakim, Joao R Galante, Huma Zahid, et al.
ALTEX|January 24, 2023
Incorporating new approach methodologies into regulatory nonclinical pharmaceutical safety assessmentJan Turner, Pandora Pound, Carla Owen, et al.
ALTEX|November 1, 2024
Corrigendum to Incorporating new approach methodologies into regulatory nonclinical pharmaceutical safety assessmentJan Turner, Pandora Pound, Carla Owen, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Regulatory Toxicology and Pharmacology : RTP|April 29, 2014
The added value of the 90-day repeated dose oral toxicity test for industrial chemicals with a low (sub)acute toxicity profile in a high quality datasetKaty Taylor, David J Andrew, Laura Rego
ALTEX|March 11, 2014
Experiences of the REACH testing proposals system to reduce animal testingKaty Taylor, Wolfgang Stengel, Carlotta Casalegno, et al.
Alternatives to Laboratory Animals : ATLA|July 30, 2008
Estimates for worldwide laboratory animal use in 2005Katy Taylor, Nicky Gordon, Gill Langley, et al.
ALTEX|April 17, 2026
Implementation of reduction and refinement-related parameters in repeated dose toxicity studiesKaty Taylor, Laura Rego Alvarez, Emma Grange, et al.
Applied Occupational and Environmental Hygiene|May 15, 2003
Video exposure assessments demonstrate excessive laboratory formaldehyde exposuresTimothy J Ryan, G Edward Burroughs, Katy Taylor, et al.
NAM Journal|June 29, 2026
Botulinum neurotoxin: Tracking the transition from lethal dose to <i>in vitro</i> modelsJustine C Watkins, Jordi Middelkoop, Katy Taylor, et al.
Annals of Palliative Medicine|April 21, 2023
Evaluating the impact of the metastatic spinal cord compression coordinator in a regional cancer network: a prospective, non-randomized pilot studyRubyyat-A Hakim, Joao R Galante, Huma Zahid, et al.
ALTEX|January 24, 2023
Incorporating new approach methodologies into regulatory nonclinical pharmaceutical safety assessmentJan Turner, Pandora Pound, Carla Owen, et al.
ALTEX|November 1, 2024
Corrigendum to Incorporating new approach methodologies into regulatory nonclinical pharmaceutical safety assessmentJan Turner, Pandora Pound, Carla Owen, et al.
Pageof 3